Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats

Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated. This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolep...

Full description

Saved in:
Bibliographic Details
Published inPsychopharmacologia Vol. 192; no. 4; pp. 571 - 580
Main Authors Baeckstroem, Pia, Hyytiae, Petri
Format Journal Article
LanguageEnglish
Published Berlin Springer 01.07.2007
Springer Nature B.V
Subjects
Rat
Online AccessGet full text
ISSN0033-3158
1432-2072
DOI10.1007/s00213-007-0753-8

Cover

Abstract Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated. This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-D-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking. Wistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 microg/side), the NMDA antagonist D-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 microg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 microg/side) on reinstatement were examined in a within-subjects design. CNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets. The results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior.
AbstractList Rationale: Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated. Objective: This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-d-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking. Method: Wistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 mu g/side), the NMDA antagonist d-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 mu g/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 mu g/side) on reinstatement were examined in a within-subjects design. Results: CNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets. Conclusions: The results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior.
RATIONALE: Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated. OBJECTIVE: This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-D-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking. METHOD: Wistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 microg/side), the NMDA antagonist D-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 microg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 microg/side) on reinstatement were examined in a within-subjects design. RESULTS: CNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets. CONCLUSIONS: The results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior. [PUBLICATION ABSTRACT]
RationaleNucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated.ObjectiveThis study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-d-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking.MethodWistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 μg/side), the NMDA antagonist d-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 μg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 μg/side) on reinstatement were examined in a within-subjects design.ResultsCNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets.ConclusionsThe results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior.
Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated. This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-D-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking. Wistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 microg/side), the NMDA antagonist D-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 microg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 microg/side) on reinstatement were examined in a within-subjects design. CNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets. The results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior.
Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated.RATIONALENucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated.This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-D-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking.OBJECTIVEThis study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-D-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking.Wistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 microg/side), the NMDA antagonist D-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 microg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 microg/side) on reinstatement were examined in a within-subjects design.METHODWistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 microg/side), the NMDA antagonist D-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 microg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 microg/side) on reinstatement were examined in a within-subjects design.CNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets.RESULTSCNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets.The results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior.CONCLUSIONSThe results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior.
Author Hyytiä, Petri
Bäckström, Pia
Author_xml – sequence: 1
  givenname: Pia
  surname: Baeckstroem
  fullname: Baeckstroem, Pia
– sequence: 2
  givenname: Petri
  surname: Hyytiae
  fullname: Hyytiae, Petri
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18834204$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17347848$$D View this record in MEDLINE/PubMed
BookMark eNqF0k9rFTEQAPAgFfta_QBeJCj21Nj82032-GhtLbTqQc9LNjuraXeTZ7Ip9Dv4oc3yXikU1FwSmN_MEGYO0J4PHhB6zegHRqk6SZRyJkh5EqoqQfQztGJScMKp4ntoRakQRLBK76ODlG5oOVLLF2ifKSGVlnqFfl_6uzDewQR-xmHA6-uv65Nb47yZ4Rh_vj5bH2PjezxdjLnCESxs5hATdh7PPwH7bEfICRtr89SBT9iGCEvUZiDO99lCX9KcT3Op-NDFBltaAE4At87_WHw0c3qJng9mTPBqdx-i7-cfv51-IldfLi5P11fESlbNRFS1kKDqjvFGdn3HwRgmtOqF6pSUPR9YpUSJguZDDY0wPa3BDrpr7ACMikN0tK27ieFXhjS3k0sWxtF4CDm1ilZ1Iyn_L2RN3ZTOrMB3T-BNyNGXT7S8riuhqZR1UW__qphuilOyoDc7lLsJ-nYT3WTiffswswLe74BJ1oxDNN669Oi0FpLTpRDbOhtDShGGR0LbZX_a7f60y3PZn3aprZ7kWFcG54Kfo3HjPzL_AEiwx0M
CODEN PSYPAG
CitedBy_id crossref_primary_10_1016_j_tips_2017_12_004
crossref_primary_10_1016_j_ejphar_2010_01_029
crossref_primary_10_1038_npp_2010_48
crossref_primary_10_1016_j_neulet_2020_135470
crossref_primary_10_1111_gbb_12348
crossref_primary_10_1002_wmts_18
crossref_primary_10_1007_s00213_016_4384_9
crossref_primary_10_1016_j_bbr_2009_03_039
crossref_primary_10_1016_j_jgr_2021_05_007
crossref_primary_10_1523_ENEURO_0029_21_2021
crossref_primary_10_1016_j_brainres_2008_02_106
crossref_primary_10_1038_nrn2515
crossref_primary_10_1101_cshperspect_a039628
crossref_primary_10_3389_fnbeh_2018_00017
crossref_primary_10_1111_j_1476_5381_2010_01088_x
crossref_primary_10_1126_sciadv_abo6574
crossref_primary_10_1007_s00213_011_2565_0
crossref_primary_10_1111_j_1369_1600_2011_00325_x
crossref_primary_10_12659_MSM_881802
crossref_primary_10_1007_s00213_012_2897_4
crossref_primary_10_1111_j_1471_4159_2008_05518_x
crossref_primary_10_1196_annals_1441_013
crossref_primary_10_1016_j_neuropharm_2021_108452
crossref_primary_10_1111_adb_12122
crossref_primary_10_1111_ejn_12491
crossref_primary_10_1016_j_brainresbull_2011_10_021
crossref_primary_10_1016_j_neuropharm_2018_07_003
crossref_primary_10_1111_adb_12127
crossref_primary_10_1124_pr_116_012484
crossref_primary_10_1111_jnc_13524
crossref_primary_10_1007_s00213_013_3106_9
crossref_primary_10_1111_j_1471_4159_2010_06851_x
crossref_primary_10_1007_s00213_010_1868_x
crossref_primary_10_1016_j_euroneuro_2008_04_010
crossref_primary_10_1007_s00213_008_1234_4
crossref_primary_10_1111_j_1471_4159_2009_06140_x
crossref_primary_10_1016_j_neuropharm_2024_110081
crossref_primary_10_1523_JNEUROSCI_1264_10_2010
crossref_primary_10_1111_j_1460_9568_2012_07991_x
crossref_primary_10_1016_j_brainres_2007_09_035
crossref_primary_10_1016_j_pharmthera_2009_11_002
crossref_primary_10_1038_npp_2008_140
crossref_primary_10_1016_j_neubiorev_2017_02_024
crossref_primary_10_1016_j_brainres_2014_09_004
crossref_primary_10_1007_s00213_010_1890_z
crossref_primary_10_1016_j_bbr_2010_08_012
crossref_primary_10_1523_JNEUROSCI_0503_13_2013
crossref_primary_10_1016_j_biopsych_2009_09_016
crossref_primary_10_3389_fnbeh_2023_1305412
crossref_primary_10_1111_bph_12735
crossref_primary_10_1093_ijnp_pyw086
crossref_primary_10_1016_j_neubiorev_2022_104584
crossref_primary_10_1016_j_bbr_2017_06_017
crossref_primary_10_1016_j_neuropharm_2017_12_008
crossref_primary_10_1371_journal_pone_0068371
crossref_primary_10_1523_JNEUROSCI_1432_21_2022
crossref_primary_10_1111_adb_12740
crossref_primary_10_1007_s00213_013_3226_2
crossref_primary_10_1016_j_neuroscience_2008_05_015
crossref_primary_10_1038_npp_2013_175
crossref_primary_10_1016_j_bcp_2007_07_031
crossref_primary_10_1016_j_cobeha_2018_06_014
crossref_primary_10_1016_j_brs_2021_11_003
crossref_primary_10_1111_j_1749_6632_2009_05144_x
crossref_primary_10_1124_jpet_117_244822
crossref_primary_10_1016_j_pbb_2010_06_005
crossref_primary_10_1016_j_addbeh_2010_11_003
crossref_primary_10_1007_s00429_015_1170_0
crossref_primary_10_1007_s10571_022_01223_6
crossref_primary_10_1016_j_brainres_2012_05_014
crossref_primary_10_1038_nn_3445
crossref_primary_10_1007_s00213_019_05208_0
crossref_primary_10_1007_s00213_011_2447_5
crossref_primary_10_1038_npp_2015_92
crossref_primary_10_1111_j_1369_1600_2011_00432_x
crossref_primary_10_1523_JNEUROSCI_1221_08_2008
crossref_primary_10_1111_j_1530_0277_2009_01030_x
crossref_primary_10_1016_j_mehy_2008_03_043
crossref_primary_10_1111_adb_12690
crossref_primary_10_1021_jm900172f
crossref_primary_10_1007_s00213_009_1624_2
crossref_primary_10_1016_j_bbr_2008_09_027
crossref_primary_10_1038_sj_npp_1301473
crossref_primary_10_1007_s00213_009_1700_7
crossref_primary_10_1523_JNEUROSCI_3710_12_2013
crossref_primary_10_1523_JNEUROSCI_5129_07_2008
crossref_primary_10_1038_s41598_019_51556_4
crossref_primary_10_3390_healthcare9040376
crossref_primary_10_1007_s00213_007_0904_y
crossref_primary_10_1111_bph_13437
crossref_primary_10_1016_j_biopsych_2012_07_019
crossref_primary_10_1016_j_neuron_2010_06_004
crossref_primary_10_1016_j_pbb_2012_01_014
crossref_primary_10_1016_j_neulet_2012_07_042
crossref_primary_10_1016_j_neubiorev_2020_07_025
crossref_primary_10_1038_bjp_2008_51
crossref_primary_10_1016_j_bbr_2016_08_011
crossref_primary_10_1007_s00213_012_2804_z
crossref_primary_10_4196_kjpp_2021_25_1_79
crossref_primary_10_1038_mp_2011_46
crossref_primary_10_1016_j_jneuroim_2011_06_002
crossref_primary_10_1523_JNEUROSCI_3236_14_2014
crossref_primary_10_1523_JNEUROSCI_2550_10_2010
crossref_primary_10_1016_j_biopsych_2014_02_005
crossref_primary_10_1038_sj_npp_1301623
crossref_primary_10_1016_j_neuropharm_2012_08_006
crossref_primary_10_1016_j_pharmthera_2012_01_010
crossref_primary_10_1111_j_1460_9568_2008_06199_x
crossref_primary_10_1007_s12035_014_8926_z
crossref_primary_10_1007_s12640_014_9502_z
crossref_primary_10_1016_j_bcp_2007_06_039
crossref_primary_10_1038_s41598_018_22087_1
crossref_primary_10_1007_s12640_010_9176_0
crossref_primary_10_1124_pharmrev_121_000540
crossref_primary_10_1124_pr_109_001933
crossref_primary_10_1016_j_coph_2008_12_003
crossref_primary_10_1098_rstb_2008_0084
Cites_doi 10.1007/s00213-002-1328-3
10.1016/S0893-133X(99)00157-8
10.1038/sj.mp.4001269
10.1046/j.0953-816x.2001.01804.x
10.1002/syn.10166
10.1523/JNEUROSCI.22-07-02916.2002
10.1007/s00213-001-0953-6
10.1007/s002130050774
10.1038/sj.npp.1300845
10.1111/j.1471-4159.2005.03517.x
10.1016/S0149-7634(02)00007-6
10.1046/j.1471-4159.1999.0722397.x
10.1523/JNEUROSCI.21-21-08655.2001
10.1038/nn1579
10.1016/S0893-133X(00)00100-7
10.1007/s00213-004-2069-2
10.1007/BF02245266
10.1016/S0306-4522(99)00214-6
10.1007/s002139900340
10.1016/S0028-3908(02)00309-X
10.1177/026988119801200104
10.1101/lm.81404
10.1007/s00213-002-1224-x
10.1038/sj.npp.1300381
10.1016/j.drugalcdep.2006.04.003
10.1038/nn1383
10.1523/JNEUROSCI.2252-05.2005
10.1038/nn1217
10.1007/s00213-002-1196-x
10.1016/j.ejphar.2005.09.034
10.1046/j.1471-4159.2003.01824.x
10.1001/archpsyc.58.4.334
10.1523/JNEUROSCI.20-15-j0006.2000
10.1007/s00213-004-1895-6
10.1038/sj.npp.1300851
10.1176/appi.ajp.158.7.1075
10.1016/0301-0082(80)90018-0
10.1523/JNEUROSCI.23-08-03531.2003
10.1016/S0893-133X(01)00235-4
10.1523/JNEUROSCI.23-03-00742.2003
10.1007/s00213-003-1432-z
ContentType Journal Article
Copyright 2007 INIST-CNRS
Springer-Verlag 2007
Springer-Verlag 2007.
Copyright_xml – notice: 2007 INIST-CNRS
– notice: Springer-Verlag 2007
– notice: Springer-Verlag 2007.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QR
7RV
7TK
7X7
7XB
88E
88G
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
K9.
KB0
M0S
M1P
M2M
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
DOI 10.1007/s00213-007-0753-8
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Chemoreception Abstracts
Nursing & Allied Health Database
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
Animal Behavior Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Neurosciences Abstracts
ProQuest One Psychology
ProQuest One Psychology
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1432-2072
EndPage 580
ExternalDocumentID 1282661481
17347848
18834204
10_1007_s00213_007_0753_8
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID .55
3SX
40D
40E
95.
95~
AAYXX
ABMNI
AGWIL
ALMA_UNASSIGNED_HOLDINGS
CITATION
KOW
N2Q
R9-
RHV
SBY
SOJ
X7M
~EX
-4W
-BR
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QR
7RV
7TK
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GNUQQ
K9.
M1P
M2M
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
ID FETCH-LOGICAL-c415t-35634e76b1294bdb2eaa1387d37b744d2f1573b12e82f6e93ad06ecf8b9cfe103
IEDL.DBID 7X7
ISSN 0033-3158
IngestDate Fri Jul 11 11:18:14 EDT 2025
Fri Jul 11 01:01:29 EDT 2025
Sun Aug 17 09:11:17 EDT 2025
Sun Aug 17 09:11:22 EDT 2025
Sat Sep 28 08:19:45 EDT 2024
Tue Sep 20 22:41:05 EDT 2022
Tue Jul 01 04:16:30 EDT 2025
Thu Apr 24 23:03:26 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Agonist
Relapse
Rat
Psychotropic
Central nervous system
Glutamate receptor
Encephalon
Kainate receptor
Ester
Drug of abuse
Conditioning
Glutamate receptors
mglu5 glutamate receptor
CNS stimulant
Rodentia
Basal ganglion
Nucleus accumbens
Vertebrata
Mammalia
Addiction
Metabotropic receptor
Animal
Cocaine
NMDA receptor
Kainic acid
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c415t-35634e76b1294bdb2eaa1387d37b744d2f1573b12e82f6e93ad06ecf8b9cfe103
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 17347848
PQID 218965374
PQPubID 47309
PageCount 10
ParticipantIDs proquest_miscellaneous_70569402
proquest_miscellaneous_19691381
proquest_journals_2665380446
proquest_journals_218965374
pubmed_primary_17347848
pascalfrancis_primary_18834204
crossref_primary_10_1007_s00213_007_0753_8
crossref_citationtrail_10_1007_s00213_007_0753_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2007-07-01
PublicationDateYYYYMMDD 2007-07-01
PublicationDate_xml – month: 07
  year: 2007
  text: 2007-07-01
  day: 01
PublicationDecade 2000
PublicationPlace Berlin
PublicationPlace_xml – name: Berlin
– name: Germany
– name: Heidelberg
PublicationTitle Psychopharmacologia
PublicationTitleAlternate Psychopharmacology (Berl)
PublicationYear 2007
Publisher Springer
Springer Nature B.V
Publisher_xml – name: Springer
– name: Springer Nature B.V
References WK Park (753_CR34) 2002; 22
P Bäckström (753_CR3) 2004; 29
NE Paterson (753_CR35) 2003; 167
L Lu (753_CR27) 2003; 85
RE See (753_CR39) 2005; 526
JL Cornish (753_CR10) 1999; 93
JL Cornish (753_CR9) 2000; 20
K McFarland (753_CR30) 2003; 23
Y Shaham (753_CR41) 2003; 161
RW Foltin (753_CR14) 2000; 149
L Lu (753_CR28) 2005; 8
CD Kilts (753_CR24) 2001; 58
G Paxinos (753_CR36) 1997
PJ Kenny (753_CR23) 2005; 179
AA Harrison (753_CR18) 2002; 160
JW Grimm (753_CR17) 2003; 23
F Schneider (753_CR38) 2001; 158
G Hotsenpiller (753_CR21) 2001; 14
J McLaughlin (753_CR32) 2003; 168
P Bäckström (753_CR2) 2006; 31
P Di Ciano (753_CR11) 2001; 25
L Churchill (753_CR8) 1999; 72
AC Boudreau (753_CR5) 2005; 25
ST Tiffany (753_CR42) 1998; 12
K McFarland (753_CR29) 2001; 21
RA Fuchs (753_CR15) 2004; 176
M Arroyo (753_CR1) 1998; 140
RJ Hayes (753_CR19) 2003; 168
SB Caine (753_CR6) 1993
R Ito (753_CR22) 2004; 7
RN Cardinal (753_CR7) 2002; 26
BJ Everitt (753_CR13) 2005; 8
GJ Mogenson (753_CR33) 1980; 14
K Bell (753_CR4) 2000; 23
DW Self (753_CR40) 2004; 11
TM Tzschentke (753_CR43) 2003; 8
JW Grimm (753_CR16) 2000; 22
TR Kosten (753_CR25) 2006; 31
AJ McGeehan (753_CR31) 2003; 47
RN Ehrman (753_CR12) 1992; 107
SE Hemby (753_CR20) 2005; 95
KD Lominac (753_CR26) 2006; 85
P Popik (753_CR37) 2002; 43
References_xml – volume: 168
  start-page: 75
  year: 2003
  ident: 753_CR19
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-002-1328-3
– volume: 22
  start-page: 473
  year: 2000
  ident: 753_CR16
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(99)00157-8
– volume: 8
  start-page: 373
  year: 2003
  ident: 753_CR43
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001269
– volume: 14
  start-page: 1843
  year: 2001
  ident: 753_CR21
  publication-title: Eur J Neurosci
  doi: 10.1046/j.0953-816x.2001.01804.x
– volume: 47
  start-page: 240
  year: 2003
  ident: 753_CR31
  publication-title: Synapse
  doi: 10.1002/syn.10166
– volume: 22
  start-page: 2916
  year: 2002
  ident: 753_CR34
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-07-02916.2002
– start-page: 117
  volume-title: Behavioral neuroscience: a practical approach
  year: 1993
  ident: 753_CR6
– volume: 160
  start-page: 56
  year: 2002
  ident: 753_CR18
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-001-0953-6
– volume: 140
  start-page: 331
  year: 1998
  ident: 753_CR1
  publication-title: Psychopharmacology
  doi: 10.1007/s002130050774
– volume: 31
  start-page: 778
  year: 2006
  ident: 753_CR2
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300845
– volume: 95
  start-page: 1785
  year: 2005
  ident: 753_CR20
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2005.03517.x
– volume: 26
  start-page: 321
  year: 2002
  ident: 753_CR7
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/S0149-7634(02)00007-6
– volume: 72
  start-page: 2397
  year: 1999
  ident: 753_CR8
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1999.0722397.x
– volume: 21
  start-page: 8655
  year: 2001
  ident: 753_CR29
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.21-21-08655.2001
– volume: 8
  start-page: 1481
  year: 2005
  ident: 753_CR13
  publication-title: Nat Neurosci
  doi: 10.1038/nn1579
– volume: 23
  start-page: 335
  year: 2000
  ident: 753_CR4
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(00)00100-7
– volume: 179
  start-page: 247
  year: 2005
  ident: 753_CR23
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-004-2069-2
– volume: 107
  start-page: 523
  year: 1992
  ident: 753_CR12
  publication-title: Psychopharmacology
  doi: 10.1007/BF02245266
– volume: 93
  start-page: 1359
  year: 1999
  ident: 753_CR10
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(99)00214-6
– volume: 149
  start-page: 24
  year: 2000
  ident: 753_CR14
  publication-title: Psychopharmacology
  doi: 10.1007/s002139900340
– volume: 43
  start-page: 1210
  year: 2002
  ident: 753_CR37
  publication-title: Neuropharmacology
  doi: 10.1016/S0028-3908(02)00309-X
– volume: 12
  start-page: 23
  year: 1998
  ident: 753_CR42
  publication-title: J Psychopharmacol
  doi: 10.1177/026988119801200104
– volume: 11
  start-page: 648
  year: 2004
  ident: 753_CR40
  publication-title: Learn Mem
  doi: 10.1101/lm.81404
– volume: 161
  start-page: 3
  year: 2003
  ident: 753_CR41
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-002-1224-x
– volume: 29
  start-page: 921
  year: 2004
  ident: 753_CR3
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300381
– volume: 85
  start-page: 142
  year: 2006
  ident: 753_CR26
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2006.04.003
– volume: 8
  start-page: 212
  year: 2005
  ident: 753_CR28
  publication-title: Nat Neurosci
  doi: 10.1038/nn1383
– volume-title: The rat brain in stereotaxic coordinates
  year: 1997
  ident: 753_CR36
– volume: 25
  start-page: 9144
  year: 2005
  ident: 753_CR5
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2252-05.2005
– volume: 7
  start-page: 389
  year: 2004
  ident: 753_CR22
  publication-title: Nat Neurosci
  doi: 10.1038/nn1217
– volume: 168
  start-page: 57
  year: 2003
  ident: 753_CR32
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-002-1196-x
– volume: 526
  start-page: 140
  year: 2005
  ident: 753_CR39
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2005.09.034
– volume: 85
  start-page: 1604
  year: 2003
  ident: 753_CR27
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.2003.01824.x
– volume: 58
  start-page: 334
  year: 2001
  ident: 753_CR24
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.58.4.334
– volume: 20
  start-page: 1
  year: 2000
  ident: 753_CR9
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.20-15-j0006.2000
– volume: 176
  start-page: 459
  year: 2004
  ident: 753_CR15
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-004-1895-6
– volume: 31
  start-page: 644
  year: 2006
  ident: 753_CR25
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300851
– volume: 158
  start-page: 1075
  year: 2001
  ident: 753_CR38
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.158.7.1075
– volume: 14
  start-page: 69
  year: 1980
  ident: 753_CR33
  publication-title: Prog Neurobiol
  doi: 10.1016/0301-0082(80)90018-0
– volume: 23
  start-page: 3531
  year: 2003
  ident: 753_CR30
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-08-03531.2003
– volume: 25
  start-page: 341
  year: 2001
  ident: 753_CR11
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(01)00235-4
– volume: 23
  start-page: 742
  year: 2003
  ident: 753_CR17
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-03-00742.2003
– volume: 167
  start-page: 257
  year: 2003
  ident: 753_CR35
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-003-1432-z
SSID ssj0000484
ssj0068394
Score 2.2798622
Snippet Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking...
RATIONALE: Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug...
RationaleNucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug...
Rationale: Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 571
SubjectTerms 2-Amino-5-phosphonovalerate - pharmacology
6-Cyano-7-nitroquinoxaline-2,3-dione - pharmacology
Animal behavior
Animal memory
Animal training
Animals
Biological and medical sciences
Cocaine
Cocaine - administration & dosage
Cocaine-Related Disorders - physiopathology
Cocaine-Related Disorders - psychology
Conditioning, Psychological - drug effects
Cues
Dopamine Uptake Inhibitors - administration & dosage
Dose-Response Relationship, Drug
Drug abuse
Drug addiction
Excitatory Amino Acid Antagonists - pharmacology
Extinction, Psychological - drug effects
Glutamic acid receptors
Glutamic acid receptors (ionotropic)
Glutamic acid receptors (metabotropic)
Locomotor activity
Male
Medical sciences
Motor Activity - drug effects
N-Methyl-D-aspartic acid receptors
Neuropharmacology
Neurotransmitters
Nucleus accumbens
Nucleus Accumbens - drug effects
Nucleus Accumbens - physiopathology
Pharmacology
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Pyridines - pharmacology
Quinoxaline
Rats
Rats, Wistar
Receptor, Metabotropic Glutamate 5
Receptors, Kainic Acid - antagonists & inhibitors
Receptors, Kainic Acid - physiology
Receptors, Metabotropic Glutamate - antagonists & inhibitors
Receptors, Metabotropic Glutamate - physiology
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Receptors, N-Methyl-D-Aspartate - physiology
Reinstatement
Rodents
Second-order schedule
Self Administration
Sucrose
α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
Title Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats
URI https://www.ncbi.nlm.nih.gov/pubmed/17347848
https://www.proquest.com/docview/218965374
https://www.proquest.com/docview/2665380446
https://www.proquest.com/docview/19691381
https://www.proquest.com/docview/70569402
Volume 192
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1da9swFBVbC2NQxtZ9ee0yPYw-jJhKlizJTyPZmnWDhDBayJuxZQnKOied44f-h_3o3euPmMLapzhcCRtf6epI1_ccQj66PLYZ9yyMTeFgg1Ko0HChwiSKXMQzDzERC5znC3V-KX-s4lX3bU7VfVbZx8QmUBdri2fkp7AUJSoWWn7e3IQoGoXJ1U5B4zHZ5wBEULlBr_QQiCXWYLZ_FACBlpFZYD1ZbPoMJ2sIRSPUOGgO7WIRmjtr1MEmq-B1-Vbn4n4g2ixIs-fkWYck6aR1_QvyyJWH5Mm8y5UfkpNly0p9O6YXQ5FVNaYndDnwVd--JH-_lxCjGt7wLV17OpkvJ6e_sKpq68Z0Mf86GdOsLOjvb9d1TCFCug1K9NCrkgJ6pCUyItcVzaxFdZGyosiMiVZbuxC2_DB4Cuh2VTbFS_1dIBDDLRytnMPTemwPg7F6RS5nZxdfzsNOpCG0sPZvQxErIZ1WOQAHmRd55LKMC6MLoXMtZRF5HmsBVmcir1wisoIpZ73JE-sdZ-I12SvXpXtLaJJ5FXsOmJFJ6ZlJwE1a58JyaVmes4Cw3i2p7RjMUUjjOt1xLzeeTPESPZmagHzaddm09B0PNR7d8fXQwxghIyYDctQ7P-2mepXuBmZAjv9jVWAzmDUPyIedGaYw5mWy0q3rKkWGInhl_P4WGmBqAjv9gLxph9zwaFpIbaR59-CjHZGn_Zk048dkb_undu8BTG3zUTNlRmR_MptOF_A7PVssf_4DQJUccw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEB2VVAIkhKDcTEu7D9AHFKvr3bW9fqhQoC0JbaIItVLfjC-7UkRxAk6E8g_8Ev_GjC-JKtG-9S3R7MZWzu7MeMdzDsBbk_pZ4lnu-jo3-ICSB672ZOBGQhjhJRZ9IjU4D0dB_0J9ufQvN-Bv2wtDr1W2PrFy1Pk0ozPyAwxFUeDLUH2Y_XRJNIqKq62CRtIoK-SHFcNY09dxapa_8QmuPBwcIdzvhDg5Pv_UdxuRATfD2DV3pR9IZcIgxcCn0jwVJkk8qcNchmmoVC6s54cSrUYLG5hIJjkPTGZ1GmXWeFzi796DTUXnJx3Y_Hg8Gn9dhwJFXaD1lwBTkZoTWlJHm6_bGiuvKE0FqSxUx4a-dPW1KPlolpQImK2VNm5OhauQePIEHje5LOvVi-8pbJhiC-4Pm2r9FuyPa17sZZedr9u8yi7bZ-M1Y_byGfwZFOglK-byOZta1huOewffqa9rbrpsNDzqdVlS5OzH56uFz9BHmxmJBLFJwTB_ZQVxMi9KhviQvklRMuLmJGu2MO6kyHH55jhtUlTtU-1VMBTgJQwrjaF6AY3H7VA-h4s7QfAFdIppYV4BixIb-NbDrJUrZbmOEKYwTGXmqYynKXeAt7DEWcOhTlIeV_GK_blCMqaPhGSsHXi_mjKrCURuG7x7Dev1DK2lElw5sN2CHzfOpoxXW8OBnf9YA7Rpqts7sLcyoxOhylBSmOmijIkjCf8y7-YRISbKkeLCgZf1klvfWihVqJV-feut7cGD_vnwLD4bjE634WF7Qs69HejMfy3MG0zt5ulus4EYfLvrPfsPqVFc-Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGJk1ICMG4hY3ND7AH1KiO7djOw4QK3VgZrSq0SXvLktiWKoZbSCvU_8Af419xnEurSWxve0t17CTq53OxT853EHpr8rjIIkvCWGkDGxQtQhUxESaUGhplFmyiL3AejsTpBf9yGV9uoL9tLYz_rLK1iZWh1tPCn5F3wRUlImaSd23zVcS4f_Jh9jP0DaR8orXtppE1XRb0UcU21tR4nJnlb9jNlUeDPkD_jtKT4_NPp2HTcCAswI_NQxYLxo0UOThBnuucmiyLmJKayVxyrqmNYslAahS1wiQs00SYwqo8KayJCIP7PkBbEpw-7AO3Ph6Pxt_WboH7itD6h4CwpOaHZr66LVZtvpVU9KbUd1yojhBjFqobHvPRLCsBPFt33bg9LK7c48kT9LiJa3GvXohP0YZxO2h72GTud9DhuObIXnbw-brkq-zgQzxes2cvn6E_AwcWs2Ixn-Opxb3huNf97mu85qaDR8N-r4Mzp_GPz9eLGIO9NjPfMAhPHIZYFjvPz7woMeDje524EnueTi8tFiacOA1LWcO0iatKqdqngFuARxhcGuNzB348qEb5HF3cC4Iv0KabOvMK4SSzIrYRRLCEc0tUAjBJmbMi4gXJcxIg0sKSFg2fum_rcZ2umKArJFN_6ZFMVYDer6bMajKRuwbv38B6PUMpxinhAdptwU8bw1OmKzUJ0N5_pAJkyufwA3SwEoNB8VmizJnpokw9XxL8ZdHtIyQEzQknNEAv6yW3fjXJuFRcvb7z1Q7QNuhu-nUwOttFD9vDchLtoc35r4V5A1HePN9v9Aejq_tW2X9iqWE9
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Involvement+of+AMPA%2Fkainate%2C+NMDA%2C+and+mGlu5+receptors+in+the+nucleus+accumbens+core+in+cue-induced+reinstatement+of+cocaine+seeking+in+rats&rft.jtitle=Psychopharmacology&rft.au=B%C3%A4ckstr%C3%B6m%2C+Pia&rft.au=Hyyti%C3%A4%2C+Petri&rft.date=2007-07-01&rft.issn=0033-3158&rft.eissn=1432-2072&rft.volume=192&rft.issue=4&rft.spage=571&rft.epage=580&rft_id=info:doi/10.1007%2Fs00213-007-0753-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00213_007_0753_8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon